Administered by:
#UniversalFluVaccine has promising clinical trial results https://www.skepticalraptor.com/skepticalraptorblog.php/universal-flu-vaccine-has-promising-clinical-trial-results/
OVX836 is a recombinant #H1N1 #nucleoprotein #vaccine. Nucleoprotein is a relatively stable protein in viral particles — not prone to the mutations that change surface antigens so often that new strains are constantly emerging. Presenting this stable protein as an antigen could reduce the need for constant #flu vaccine updating.
“The #vaccine effectiveness was 84%, with four cases of #influenzaA in the 33-patient placebo group, and two cases among the 104 patients who received the vaccine.
The vaccine had a good safety profile and tolerability. No serious adverse events were observed.”